Squarepoint
MIRM icon

Squarepoint’s Mirum Pharmaceuticals MIRM Stock Holding History

Squarepoint’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Sell
2,896
-58,796
-95% -$5.9M ﹤0.01% 3716
2026
Q1 		$5.7M Sell
61,692
-110,734
-64% -$10.4M 0.01% 1403
2025
Q4 		$13.6M Buy
172,426
+44,523
+35% +$3.2M 0.01% 933
2025
Q3 		$9.38M Buy
127,903
+109,626
+600% +$6.97M 0.01% 1105
2025
Q2 		$930K Sell
18,277
-16,185
-47% -$721K ﹤0.01% 2726
2025
Q1 		$1.55M Buy
34,462
+12,780
+59% +$602K ﹤0.01% 2296
2024
Q4 		$897K Buy
+21,682
New +$904K ﹤0.01% 3162
2024
Q3 		– Sell
-67,421
Closed -$2.31M – 4472
2024
Q2 		$2.31M Buy
67,421
+26,154
+63% +$686K ﹤0.01% 1946
2024
Q1 		$1.04M Sell
41,267
-90,945
-69% -$2.5M ﹤0.01% 2565
2023
Q4 		$3.9M Buy
132,212
+32,555
+33% +$985K 0.01% 1551
2023
Q3 		$3.15M Buy
99,657
+62,398
+167% +$1.71M 0.01% 1488
2023
Q2 		$964K Buy
+37,259
New +$991K ﹤0.01% 2185
2023
Q1 		– Sell
-15,117
Closed -$295K – 3560
2022
Q4 		$295K Buy
+15,117
New +$299K ﹤0.01% 2589
2021
Q1 		– Sell
-21,441
Closed -$374K – 3425
2020
Q4 		$374K Sell
21,441
-2,220
-9% -$43.6K ﹤0.01% 2045
2020
Q3 		$456K Sell
23,661
-4,326
-15% -$92.8K 0.01% 1504
2020
Q2 		$545K Sell
27,987
-6,879
-20% -$115K 0.01% 1271
2020
Q1 		$488K Buy
+34,866
New +$572K 0.01% 1057

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Squarepoint's MIRM Position: Q2 2026 in Review

Squarepoint reduced its Mirum Pharmaceuticals (MIRM) stake by 95% in Q2 2026, selling an estimated $5.9M and leaving 2,896 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #3716.

Squarepoint first reported a position in MIRM in Q1 2020 and has held it in 17 quarters since. The position peaked at $13.6M in Q4 2025. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Squarepoint held 2,896 shares of Mirum Pharmaceuticals worth $339K as of Q2 2026.
  • Squarepoint sold 58,796 Mirum Pharmaceuticals shares in Q2 2026, an estimated $5.9M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3716 holding.
  • Squarepoint first reported a position in Mirum Pharmaceuticals in Q1 2020 and has held it in 17 quarters since.
  • Squarepoint's Mirum Pharmaceuticals position peaked at $13.6M in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.